| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701968 | Journal of Thoracic Oncology | 2017 | 30 Pages |
Abstract
Heart dose is associated with OS and cardiac toxicity for patients with LA NSCLC treated with chemoradiotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Christina K. MD, PhD, Todd A. PhD, Sana MD, Alerson MD, MBA, Maria A. MD, Daniel DDS, Sandra BA, Marco MD, Jeffrey D. MD, Cliff G. MD,